Evidence map›Paper›PMID 31724825›Full record

ArticleEMBO reports2020

Extracellular microRNA 130b-3p inhibits eCIRP-induced inflammation.

Steven D Gurien, Monowar Aziz, Hui Jin, Haichao Wang, Mingzhu He, Yousef Al-Abed, Jeffrey M Nicastro, Gene F Coppa, Ping Wang

Open access · hybridAbstract read
In one paragraph

Article in EMBO reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Anti-DAMP therapies for acute inflammation.Frontiers in immunology · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. A Synthetic Poly(A) Tail Targeting Extracellular CIRP Inhibits Sepsis.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Steven D GurienCenter for Immunology and Inflammation, The Feinstein Institutes for Medical Research, Manhasset, NY, USA.
Monowar AzizCenter for Immunology and Inflammation, The Feinstein Institutes for Medical Research, Manhasset, NY, USA.
Hui JinCenter for Immunology and Inflammation, The Feinstein Institutes for Medical Research, Manhasset, NY, USA.
Haichao WangCenter for Biomedical Science, The Feinstein Institutes for Medical Research, Manhasset, NY, USA.
Mingzhu HeCenter for Molecular Innovation, The Feinstein Institutes for Medical Research, Manhasset, NY, USA.
Yousef Al-AbedCenter for Molecular Innovation, The Feinstein Institutes for Medical Research, Manhasset, NY, USA.
Jeffrey M NicastroDepartment of Surgery, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY, USA.
Gene F CoppaDepartment of Surgery, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY, USA.
Ping WangCenter for Immunology and Inflammation, The Feinstein Institutes for Medical Research, Manhasset, NY, USA.ORCID 0000-0002-1557-0394
Feinstein Institute for Medical Research · USDonald & Barbara Zucker School of Medicine at Hofstra/Northwell · US

Funding

Novel Approaches to Maintaining Organ Function in SepsisR35GM118337 · NIGMS · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI PING WANG · 2016 to 2026
$5.2M
Neutrophils in Sepsis: Role of CIRPR01GM129633 · NIGMS · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI AZIZ, MONOWAR · 2018 to 2022
$1.6M
NIGMS NIH HHS R01 GM129633NIGMS NIH HHS R35 GM118337
6 · The paper itself

Abstract

Although microRNAs regulate mRNA expression intracellularly, they are often released into the circulation in inflammatory diseases. During sepsis, secreted extracellular cold-inducible RNA-binding protein (eCIRP) acts as a damage-associated molecular pattern (DAMP), inducing tissue damage by elevating inflammatory cytokines and chemokines. Here, we report that the circulating microRNA 130b-3p inhibits eCIRP-mediated sterile and cecal ligation and puncture (CLP)-induced non-sterile inflammation. We find that levels of miR-130b-3p are increased in the serum of septic mice and patients and that it strongly interacts with recombinant murine (rm) CIRP in vitro and with eCIRP in the serum of septic mice in vivo. Combining a miR-130b-3p mimic with rmCIRP significantly decreases TNF-α release by macrophages compared to only rmCIRP-treated cells. This combined treatment also dose-dependently decreases the affinity of rmCIRP with its receptor TLR4/MD2. Finally, injection of a miR-130b-3p mimic significantly reduces rmCIRP- or CLP-induced systemic inflammation and acute lung injury in mice. These data show that extracellular miR-130b-3p functions as a novel endogenous inhibitor of eCIRP and point to an innovative therapeutic approach to treat inflammatory diseases.

Indexed as

MicroRNAsSepsisAnimalsCytokinesHumansInflammationMacrophagesMiceCytokinesMicroRNAsMIRN130 microRNA, humanMIRN130 microRNA, mouseeCIRPinflammationmacrophagesmiRNA 130b-3psepsis

Identifiers

PMID31724825
PMCPMC10563445
OpenAlexW2983493871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.